Soleno Therapeutics, Inc. (SLNO)

NCM – Real Time Price. Currency in USD

52.93

-0.01 (-0.02%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

190M

Cost of goods sold

-3M

-2M

Gross Profit

188M

-2M

Operating expenses (excl. COGS)

-173M

-182M

-37M

-23M

Operating Income

15M

-184M

-39M

-25M

Non-operating income, total

-318K

Pretax income

21M

-176M

-39M

-24M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

-415K

Net income before discontinued operations

20M

-176M

-39M

-24M

Soleno Therapeutics, Inc. (SLNO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Soleno Therapeutics, Inc. (SLNO)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Soleno Therapeutics, Inc. (SLNO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Soleno Therapeutics, Inc. (SLNO)

Income Statement (Annual)

Income Statement (Annual)